MedPath

Quality of Life Related to Different Treatment Protocols for Post-thyroidectomy Hypoparathyroidism

Not Applicable
Recruiting
Conditions
Hypoparathyroidism Postprocedural
Quality of Life
Interventions
Other: Empiric use of Calcium Carbonate and Calcitriol
Other: PTH based Calcium Carbonate and Calcitriol repletion
Registration Number
NCT03249012
Lead Sponsor
CHU de Quebec-Universite Laval
Brief Summary

This study aims to compare two different protocols commonly used in the management of post thyroidectomy hypoparathyroidism : PTH based calcium repletion and empiric repletion. The investigators aim to compare the quality of life associated with these two protocols in a randomized trial.

Detailed Description

Enrolled patients will be randomized in two treatment groups. In group 1, all patients will receive calcium carbonate and calcitriol in the post-operative period, with standardized weaning. In group 2, patients will be prescribed calcium carbonate and calcitriol only if their post-operative PTH dosage is 25% or less of the pre-operative dosage, or if post-operative PTH is inferior to 15.

The Short-Form 36 (SF-36) questionnaire (French canadian version) will be used to assess quality of life pre-operatively and at post-op week 1 and 4. Symptoms of hypocalcemia and adverse effects of calcium carbonate and calcitriol will be monitored at week 1 and 4.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Total thyroidectomy or completion hemithyroidectomy
Exclusion Criteria
  • Need for neck dissection
  • Unable to fill in questionnaires (intellectual deficit, severe psychiatric disorder, illiterate, does not speak French or English)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Empiric calcium and calcitriol repletion groupEmpiric use of Calcium Carbonate and CalcitriolAll patients in this group will receive post-operative calcium carbonate and calcitriol.
PTH based repletion groupPTH based Calcium Carbonate and Calcitriol repletionPatients in this group will be prescribed calcium carbonate and calcitriol based on their post-operative PTH.
Primary Outcome Measures
NameTimeMethod
Change from baseline quality of life at 1 and 4 weeksPre-op, 1 week post-op and 4 weeks post-op

Short Form 36 (SF-36) questionnaire

Secondary Outcome Measures
NameTimeMethod
Occurence and change in pharmacologic adverse effects of calcium carbonate and calcitriol1 week post-op, 4 weeks post-op

A questionnaire about the adverse effects of calcium carbonate and calcitriol will be completed at post-op week 1 and 4

Occurence and change in symptoms of hypocalcemia1 week post-op, 4 weeks post-op

A questionnaire about symptoms of hypocalcemia will be completed at post-op week 1 and 4.

Trial Locations

Locations (1)

CHU de Quebec

🇨🇦

Québec, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath